As billionaires race to fund anti-aging projects, a much-discussed trial goes overlooked
This story has been excerpted from the STAT Report “The race for longevity: How scientists — and industry — are seeking to extend healthy lives.”
Beating back the diseases of aging has become something of a pet project for many of Silicon Valley’s tech titans. Earlier this year, Altos Labs, a partial cellular reprogramming company, drew billions of dollars of investment, including from Jeff Bezos and Yuri Milner. Sergey Brin and Larry Page have Calico. Peter Thiel was an early backer of Unity Biotechnology. Peter Diamandis is placing bets on young blood and stem cells.
